What if it were possible to give a safe and effective vaccine to healthy women to prevent breast cancer, or at least greatly reduce the risk of breast cancer? This is a question that some researchers are actively studying, with hopes of starting clinical trials for such a preventive vaccine within a couple of years.
The National Breast Cancer Coalition (NBCC) recently published a fifth annual report on its Artemis Project: For a Preventive Breast Cancer Vaccine. The Artemis Project has reached a turning point, according to the report. With decisions about possible targets for the vaccine having been made, the research team can now begin preclinical work to develop a vaccine that could potentially be tested in early phase clinical trials starting in 2017.
